Ding, C.M. and Chiu, R.W.K. and Lau, T.K. and Leung, T.N. and Chan, L.C. and Chan, A.Y.Y. and Charoenkwan, P. and Ng, I.S.L. and Law, H.Y. and Ma, E.S.K. and Xu, X.M. and Wanapirak, C. and Sanguansermsri, T. and Liao, C. and Tan, J.A.M.A. and Chui, D.H.K. and Cantor, C.R. and Lo, Y.M.D. (2004) MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proceedings of the National Academy of Sciences of the United States of America, 101 (29). pp. 10762-10767. ISSN 0027-8424, DOI https://doi.org/10.1073/pnas.0403962101.
|
PDF
MS_analysis_of_single-nucleotide_differences_in_circulating_nucleic_acids.pdf - Published Version Download (191kB) |
Abstract
The analysis of circulating nucleic acids has revealed applications in the noninvasive diagnosis, monitoring, and prognostication of many clinical conditions. Circulating fetal-specific sequences have been detected and constitute a fraction of the total DNA in maternal plasma. The diagnostic reliability of circulating DNA analysis depends on the fractional concentration of the targeted sequence, the analytical sensitivity, and the specificity. The robust discrimination of single-nucleotide differences between circulating DNA species is technically challenging and demands the adoption of highly sensitive and specific analytical systems. We have developed a method based on single-allele base extension reaction and MS, which allows for the reliable detection of fetal-specific alleles, including point mutations and single-nucleotide polymorphisms, in maternal plasma. The approach was applied to exclude the fetal inheritance of the four most common Southeast Asian beta-thalassemia mutations in at-risk pregnancies between weeks 7 and 21 of gestation. Fetal genotypes were correctly predicted in all cases studied. Fetal haplotype analysis based on a single-nucleotide polymorphism linked to the beta-globin locus, HBB, in maternal plasma also was achieved. Consequently, noninvasive prenatal diagnosis in a mother and father carrying identical beta-thalassemia mutations was accomplished. These advances will help in catalyzing the clinical applications of fetal nucleic acids in maternal plasma. This analytical approach also will have implications for many other applications of circulating nucleic acids in areas such as oncology and transplantation.
Item Type: | Article |
---|---|
Funders: | UNSPECIFIED |
Additional Information: | Department of Molecular Medicine, Faculty of Medicine Building, University of Malaya, 50603 Kuala Lumpur, MALAYSIA |
Uncontrolled Keywords: | Molecular Medicine; Fetal haplotype |
Subjects: | R Medicine |
Divisions: | Faculty of Medicine |
Depositing User: | Ms Haslinda Lahuddin |
Date Deposited: | 08 Oct 2012 02:38 |
Last Modified: | 30 Dec 2014 02:35 |
URI: | http://eprints.um.edu.my/id/eprint/3723 |
Actions (login required)
View Item |